N/A N=30 Randomized Single-blind Treatment

Exercise Training for the Treatment of Generalized Anxiety Disorder

Generalized Anxiety Disorder

Bottom Line

View on ClinicalTrials.gov: NCT00953654 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Sep 2010

Primary outcome: Primary: Generalized Anxiety Disorder (GAD) Remission as Measured by Anxiety Disorders Interview Schedule-Adult Version (ADIS-IV) Severity Ratings — 4; 6; 7 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Strength Training (Other); Endurance Training (Other)
Age: Adult · 18+ yrs
Sex: Female
Sponsor: University of Georgia
Primary completion: May 2010

Outcome Measures

Outcome	Result	p-value
PRIMARY Generalized Anxiety Disorder (GAD) Remission as Measured by Anxiety Disorders Interview Schedule-Adult Version (ADIS-IV) Severity Ratings	4; 6; 7	—
PRIMARY Worry Symptoms	63.80; 62.1; 64.3; 59.83; 63.20; 63.4	<0.05 sig

Summary

The purpose of this study is to compare the effects of 6 weeks of endurance or strength training and a wait list comparison condition on symptoms of Generalized Anxiety Disorder (GAD).

Eligibility Criteria

Inclusion Criteria

Women aged 18-39 years
Principal diagnosis of Generalized Anxiety Disorder according to DSM-IV diagnostic criteria (comorbidities will be acceptable as long as Generalized Anxiety Disorder is the principal diagnosis)

Exclusion Criteria

A score of less than 45 on the Penn State Worry Questionnaire
A score of less than 7 on the Generalized Anxiety Disorder section of the Psychiatric Diagnostic Screening Questionnaire
Expending greater than 250 kilocalories per kilogram body weight per week as measured by a 7-day physical activity recall questionnaire
Engaging in greater than 6 exercise bouts in the month prior to recruitment
Pregnancy
Any medical contraindications (cardiovascular or musculoskeletal) to exercise training according to American College of Sports Medicine guidelines

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00953654). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.